✦ LIBER ✦

Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure

✍ Scribed by M. Sonmez; U. Cobanoglu; E. Ovali; S. B. Omay

Book ID: 108849125
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 42 KB
Volume: 33
Category: Article
ISSN: 0269-4727
DOI: 10.1111/j.1365-2710.2008.00916.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Haemorrhagic complications associated wi

Haemorrhagic complications associated with reduced α2-plasmin inhibitor during imatinib use in a patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia

✍ Kosei Matsue; Takatoshi Aoki; Jun Odawara; Shun-ichi Kimura; Masayuki Yamakura; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 349 KB

Bone marrow necrosis associated with the

Bone marrow necrosis associated with the use of imatinib mesylate in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia

✍ Kosei Matsue; Masami Takeuchi; Mihoko Koseki; Hidetaka Uryu 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 104 KB

Prospective monitoring of BCR-ABL1 trans

Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy

✍ Masamitsu Yanada; Isamu Sugiura; Jin Takeuchi; Hideki Akiyama; Atsuo Maruta; Yas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

Lack of non-hematological cross intolera

Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis

✍ Yukio Kobayashi; Hisashi Sakamaki; Shin Fujisawa; Kiyoshi Ando; Kazuhito Yamamot 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 152 KB

Effectiveness of intrathecal rituximab i

Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy

✍ José Carlos Jaime-Pérez; Laura N. Rodríguez-Romo; Oscar González-Llano; Adrián C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

The extent of minimal residual disease r

The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

✍ Seok Lee; Yoo-Jin Kim; Nak-Gyun Chung; Jihyang Lim; Dong-Gun Lee; Hee-Je Kim; Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 2 views

## Abstract ## BACKGROUND: Previously, the authors demonstrated the positive impact of imatinib on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph‐positive ALL). Here, the authors analyzed for risk factors that af